Skip to main content

$0.010 -0.001 (-9.09%)

High

$0.01

Low

$0.01

Trades

17

Turnover

$14,352

Volume

1,541,265
30 June 2023 at 3:15pm
Register to track HCT and receive email alerts.
Subject
HCT Ann: Appendix 4D and Interim Financial Report

HCT Ann: Pause in Trading

HCT Ann: Court Proceeding

HCT Ann: Trading Halt

HCT Ann: Initial Director's Interest Notice

HCT Ann: Final Director's Interest Notice

HCT Ann: Results of 2021 Annual General Meeting

HCT Ann: Board Changes

HCT Ann: AGM Presentation

HCT Ann: Quarterly Activities Report and Appendix 4C

HCT Ann: Results of Share Sale Facility for Unmarketable Parcels

HCT Ann: Notice of Annual General Meeting / Proxy Form

HCT Ann: Final Director's Interest Notice

HCT Ann: Final Director's Interest Notice

HCT Ann: Initial Director's Interest Notice

HCT Ann: Board Changes

HCT Ann: Update on Legal Dispute

HCT Ann: Maiden Order for SARS-CoV-2 test kits in Malaysia

HCT Ann: State Grant Secured to Produce Medical Grade Collagen

HCT Ann: Reinstatement to Official Quotation

HCT Ann: Collagen Market Update - Further Information

HCT Ann: Extension of existing voluntary suspension

HCT Ann: Extension of existing voluntary suspension

HCT Ann: Extension of existing voluntary suspension

HCT Ann: Suspension from Official Quotation

HCT Ann: Trading Halt

HCT Ann: Pause in Trading

HCT Ann: Collagen Market Update

HCT Ann: Unmarketable Parcels

HCT Ann: Appendix 4C - quarterly

HCT Ann: Legal Dispute

HCT Ann: Pause in Trading

HCT Ann: Investor Presentation - April 2021

HCT Ann: Appendix 4G

HCT Ann: Annual Report

HCT Ann: Change in substantial holding

HCT Ann: Appendix 4E Preliminary Final Report

HCT Ann: Holista posts resilient FY revenue and Positive 2021 outlook

HCT Ann: Appendix 4C Quarterly Cashflow Report and Commentary Revised

HCT Ann: Appendix 4C Quarterly Cashflow Report and Commentary

HCT Ann: Reinstatement to Official Quotation

HCT Ann: Holista to Launch 'List N' Disinfectant

HCT Ann: Suspension from Official Quotation

HCT Ann: Trading Halt

HCT Ann: Pause in Trading

HCT Ann: HCT Advances TGA Application on NatShield COVID-19 Labelling

HCT Ann: Holista Receives First Orders from Costanzo's for US Launch

HCT Ann: Appendix 4C Quarterly Cashflow Report and Commentary

HCT Ann: Response to ASIC Decision

HCT Ann: Pause in Trading

Register to track HCT and receive email alerts.

Similar Companies

AHY
BKL
BWX
BWX
BXN
EXL
FIJ
MCP
S66
SKN